Group profit and loss account 12 months to 31 Dec 2002 12 months to 31 Dec 2001 Restated Before Before exceptional Exceptional exceptional Exceptional items items Total items items Total Notes m m m m m m Sales including share of joint venture 1,2 1,618.2 1,618.2 1,602.5 1,602.5 Less share of joint venture sales 80.5 80.5 87.3 87.3 Group turnover 1,537.7 1,537.7 1,515.2 1,515.2 Group operating profit before exceptional items and goodwill amortisation 286.6 286.6 266.4 266.4 Exceptional items 3.
55.3 55.3 Amounts written off investments 2.4 2.4 4.4 4.4 Net interest payable 7 7.1 7.1 8.7 8.7 profit on ordinary activities before taxation 263.7 263.7 267.7 46.6 314.3 Tax on profit on ordinary activities 3,8 94.3 9.2 85.1 97.0 0.5 96.5 profit on ordinary activities after taxation 169.4 9.2 178.6 170.7 47.1 217.8 Loss profit attributable to equity minority interests 0.7 0.7 6.2 2.0 4.2 profit attributable to non-equity minority interests 0.6 0.6 2.9 2.9 Loss profit attributable to minority interests 0.1 0.1 9.1 2.0 7.1 profit for the financial year attributable to shareholders 169.5 9.2 178.7 161.6 49.1 210.7 Dividends paid and proposed 9 57.3 57.3 45.2 45.2 Retained profit for the financial year 112.2 9.2 121.4 116.4 49.1 165.5 Earnings per ordinary share 10 basic 26.1p 33.2p before exceptional items and goodwill amortisation 29.9p 26.6p average number of shares 684.7m 634.4m Diluted earnings per ordinary share after exceptional items and goodwill amortisation 25.9p 33.0p Dividends per ordinary share 9 7.80p 7.10p Share of operating profit of joint venture and associates includes income from the groups joint venture interest in Nihon Medi-Physics NMP of 23.2m 2001 26.1m.
Figures for the 12 months to 31 December 2001 have been restated following the introduction of FRS19 as explained in note 36.
All results are derived from continuing operations.
